Dalantercept in Treating Patients With Recurrent or Persistent Endometrial Cancer
Conditions
- Endometrial Adenocarcinoma
- Endometrial Clear Cell Adenocarcinoma
- Endometrial Mixed Adenocarcinoma
- Endometrial Mucinous Adenocarcinoma
- Endometrial Serous Adenocarcinoma
- Endometrial Squamous Cell Carcinoma
- Endometrial Transitional Cell Carcinoma
- Endometrial Undifferentiated Carcinoma
- Recurrent Uterine Corpus Carcinoma
Interventions
- BIOLOGICAL: Dalantercept
- OTHER: Laboratory Biomarker Analysis
Sponsor
Gynecologic Oncology Group
Collaborators